
|Videos|July 14, 2017
Dr. Hendifar on the Current Treatment Landscape in Pancreas Cancer
Author(s)Andrew E. Hendifar, MD
Andrew E. Hendifar, MD, medical oncology lead for the Gastrointestinal Disease Research Group, Cedars-Sinai Medical Center, discusses the current treatment landscape in pancreas cancer.
Advertisement
Andrew E. Hendifar, MD, medical oncology lead for the Gastrointestinal Disease Research Group, Cedars-Sinai Medical Center, discusses the current treatment landscape in pancreas cancer.
Pancreas cancer treatment is changing, say Hendifar, and the disease is treatable with combination chemotherapy.
Additionally, the community is beginning to understand the different subtypes of this disease, including BRCA and microsatellite instable. Stromal targeting therapies also look promising.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
5



































